Form 8-K - Current report:
SEC Accession No. 0001724521-25-000078
Filing Date
2025-06-12
Accepted
2025-06-12 16:21:48
Documents
13
Period of Report
2025-06-10
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rcus-20250610.htm   iXBRL 8-K 41071
2 EX-10.1 compensationprogramfornon-.htm EX-10.1 17937
  Complete submission text file 0001724521-25-000078.txt   178277

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rcus-20250610.xsd EX-101.SCH 1773
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rcus-20250610_lab.xml EX-101.LAB 21885
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rcus-20250610_pre.xml EX-101.PRE 12502
15 EXTRACTED XBRL INSTANCE DOCUMENT rcus-20250610_htm.xml XML 2714
Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 (510) 694-6200
Arcus Biosciences, Inc. (Filer) CIK: 0001724521 (see all company filings)

EIN.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38419 | Film No.: 251043001
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)